Finzati - Logo
DXCM logo

DexCom, Inc.

DXCM • Medical - Devices
$85.75
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$33.60B
Growth
—
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 17.9%Positive revenue growth · 17.2%Positive free cash flow · 2.76Consistent free cash flow · 5/5Manageable debt level · 0.51
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$85.75
Change0.00%
Shares Out391.80M
Market Cap$33.60B
Enterprise Value$33.00B
52W Range54.11 - 82.36
Beta1.45
P/E33.61
P/S6.76
P/B12.82
P/FCF23.91
EV/Sales6.64

Investment DNA

How strong this company looks for long-term investors

82
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
91/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Stable or improving margins · 17.9%Positive revenue growth · 17.2%Positive free cash flow · 2.76Consistent free cash flow · 5/5Manageable debt level · 0.51Healthy liquidity · 1.88

Analyst view

Analyst sentiment and price target

DXCM
Analyst sentiment
Based on 52 analyst votes · 2026-10-20
88/100
Bullish
Bullish
42
Hold
8
Bearish
2
Price Target
2026-07-31
Low
$64.00
Mean
$85.58
Median
$87.00
High
$96.00

Company Overview

IPO: 4/14/2005
Industry: Medical - Devices
P/B i: 12.82
Debt / Equity i: 0.51
Operating Margin: 19.56%
Net Margin: 17.94%
ROE i: -
ROIC: -

Financial Health

Score18 / 20
Debt / Equity: 0.51
Current Ratio: 1.88
Quick Ratio: 1.59
Status: Strong

Insider Transactions

Recent executive and insider activity

SAYER KEVIN R
Transaction: 07/20/2026
SELL
Change
-26,756
Price
$76.32
Filing
07/21/2026
Type
SELL
Brown Michael Jon
Transaction: 07/15/2026
SELL
Change
-1,700
Price
$74.42
Filing
07/16/2026
Type
SELL
SAYER KEVIN R
Transaction: 07/06/2026
SELL
Change
-26,756
Price
$72.00
Filing
07/07/2026
Type
SELL